Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis

Journal of Clinical Oncology

Volumn 17, Issue 1, 1999, Pages 120-129

  Goodwin, Pamela J ^a   Ennis, Marguerite ^a   Pritchard, Kathleen I ^a   McCready, David ^a   Koo, Jarley ^a   Sidlofsky, Saul ^a   Trudeau, Maureen ^a   Hood, Nicky ^a   Redwood, Sheila ^a  

^a MOUNT SINAI HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; TAMOXIFEN;

ADULT; ANTHROPOMETRY; ARTICLE; AXILLARY LYMPH NODE; BODY MASS; BREAST CARCINOMA; CALORIC INTAKE; CANCER ADJUVANT THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; WEIGHT GAIN;

EID: 0032944173     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.1.120     Document Type: Article

References (53)

1. Tartter PI, Papatestas AE, Ioannovich J, et al: Cholesterol and obesity as prognostic factors in breast cancer. Cancer 47:2222-2227, 1981
2. Goodwin PJ, Panzarella T, Boyd NF: Weight gain in women with localized breast cancer: A descriptive study. Breast Cancer Res Treat 11:59-66, 1988
3. Camoriano JK, Loprinzi CL, Ingle JN, et al: Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol 8:1327-1334, 1990
4. Bonomi P, Bunting N, Fishman D, et al: Weight gain during adjuvant chemotherapy or hormone-chemotherapy for stage II breast cancer evaluated in relation to disease free survival (DFS). Breast Cancer Res Treat 4:339, 1984 (abstr)
5. Chlebowski RT, Weiner JM, Reynolds R, et al: Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy. Breast Cancer Res Treat 7:23-29, 1986
6. Foltz AT: Weight gain among stage II breast cancer patients: A study of five factors. Oncol Nurs Forum 12:21-26, 1985
7. Subramanin VP, Raich PC, Waler BK: Weight gain in breast cancer patients undergoing chemotherapy. Breast Cancer Res Treat 1:170, 1981 (abstr)
8. Hernandez BM, Bonomi P, Hoeltgen T, et al: Weight gain during adjuvant therapy for stage II breast cancer. Breast Cancer Res Treat 3: 108, 1983 (abstr)
9. Knobf MK, Mullen JC, Xistris D, et al: Weight gain among women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum 10:28-33, 1983
10. Huntington MO: Weight gain in patients receiving adjuvant chemotherapy for carcinoma of the breast. Cancer 56:472-474, 1985
11. DeGeorge D, Gray JJ, Fetting JH, et al: Weight gain in patients with breast cancer receiving adjuvant treatment as a function of restraint, disinhibition and hunger. Oncol Nurs Forum 17:22-23, 1990 (suppl 3)
12. Levine EG, Raczynski JM, Carpenter JT: Weight gain with breast cancer adjuvant treatment. Cancer 67:1954-1959, 1991
13. Heasman KZ, Sutherland HJ, Campbell JA, et al: Weight gain during adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat 5:195-200, 1985
14. Demark-Wahnefried W, Rimer BK, Winer EP: Weight gain in women diagnosed with breast cancer. J Am Diet Assoc 97:519-526, 1997
15. Goodwin PJ, Esplen MJ, Butler K, et al: Multidisciplinary weight management in locoregional breast cancer: Results of a phase I study. Breast Cancer Res Treat 43:53-64, 1998
16. Grindel CG, Cahill CA, Walker M: Food intake of women with breast cancer during their first six months of chemotherapy. Oncol Nurs Forum 16:401-407, 1989
17. Goodwin PJ, Boyd NF: Body size and breast cancer prognosis: A critical review of the evidence. Breast Cancer Res Treat 16:205-214, 1990
18. Lees AW, Jenkins HJ, May CL, et al: Risk factors and 10-year breast cancer survival in northern Alberta, Breast Cancer Res Treat 13:143-151, 1989
19. Tretli S, Haldorsen T, Ottestad L: The effect of pre-morbid height and weight on the survival of breast cancer patients. Br J Cancer 62:299-303, 1990
20. Kyogoku S, Hirohata T, Takeshita Y, et al: Survival of breast-cancer patients and body size indicators. Int J Cancer 46:824-831, 1990
21. Kimura M: Obesity as prognostic factors in breast cancer. Diabetes Res Clin Pract 10:S247-S251, 1990 (suppl)
22. Coates RJ, Clark WAS, Eley JW, et al: Race, nutritional status, and survival from breast cancer. J Natl Cancer Inst 82:1684-1692, 1990
23. Ewertz M, Gillanders S, Meyer L, et al: Survival of breast cancer patients in relation to factors which affect the risk of developing breast cancer. Int J Cancer 49:526-530, 1991
24. Nomura AMY, LeMarchand L, Kolonel LN, et al: The effect of dietary fat on breast cancer survival among Caucasian and Japanese women in Hawaii. Breast Cancer Res Treat 18:S135-S141, 1991 (suppl)
25. Vatten LJ, Foss OP, Kvinnsland S: Overall survival of breast cancer patients in relation to preclinically determined total serum cholesterol, body mass index, height and cigarette smoking: A population-based study. Eur J Cancer 27:641-646, 1991
26. Senie RT, Rosen PP, Rhodes P, et al: Obesity at diagnosis of breast carcinoma influences duration of disease-free survival. Ann Intern Med 116:26-32, 1992
27. Gordon NH, Crowe JP, Brumberg DJ, et al: Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol 135:609-618, 1992
28. Tornberg S, Carstensen J: Serum beta-lipoprotein, serum cholesterol and Quetelet's index as predictors for survival of breast cancer patients. Eur J Cancer 29A:2025-2030, 1993
29. Bastarrachea J, Hortobagyi GN, Smith TL, et al: Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann Intern Med 119:18-25, 1993
30. Katoh A, Watzlaf VJM, D'Amico F: An examination of obesity and breast cancer survival in post-menopausal women. Br J Cancer 70:928-933, 1994
31. Obermair A, Kurz C, Hanzal E, et al: The influence of obesity on the disease-free survival in primary breast cancer. Anticancer Res 15:2265-2269, 1995
32. Den Tonkelaar I, de Waard F, Seidell JC, et al: Obesity and subcutaneous fat patterning in relation to survival of postmenopausal breast cancer patients participating in the DOM-project. Breast Cancer Res Treat 34:129-137, 1995
33. Zhang S, Folsom AR, Sellers TA, et al: Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. Cancer 76:275-283, 1995
34. Maehle BO, Tretli S: Pre-morbid body-mass-index in breast cancer: Reversed effect on survival in hormone receptor negative patients. Breast Cancer Res Treat 41:123-130, 1996
35. Rosner GL, Hargis JB, Hollis DR, et al: Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: Results from Cancer and Leukemia Group B study 8541. J Clin Oncol 14:3000-3008, 1996
36. Haybittle J, Houghton J, Baum M: Social class and weight as prognostic factors in early breast cancer. Br J Cancer 75:729-733, 1997
37. Goodwin PJ, Boyd NF, Hanna W, et al: Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk. Nutr Cancer 27:284-292, 1997
38. Del Giudice ME, Fantus IG, Ezzat S, et al: Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47:111-120, 1998
39. Sallis JF, Haskell WL, Wood PD, et al: Physical activity assessment methodology in the five-city project. Am J Epidemiol 121:91-106, 1985
40. Block G, Hartman A, Dresser CM, et al: A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124: 453-469, 1986
41. Cleary MP, Maihle NJ: The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med 216:28-43, 1997
42. Williamson DF, Kahn HS, Remington PL, et al: The 10-year incidence of overweight and major weight gain in US adults. Arch Intern Med 150:665-672, 1990
43. Svendsen OL, Hassager C, Christiansen C: Age- and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy x-ray absorptiometry. Metabolism 44:369-373, 1995
44. Levine MN, Pritchard KI, Bramwell V, et al: A randomized trial of cyclophosphamide, epirubicin, fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, fluorouracil in premenopausal women with node-positive breast cancer. J Clin Oncol 16:2651-2658, 1998
45. Bonadonna G, Brusamolino E, Valagussa P, et al: Combination chemotherapy as adjuvant treatment in operable breast cancer. N Engl J Med 294:405-410, 1976
46. Poehlman ET, Toth MJ, Gardiner AW: Changes in energy balance and body composition at menopause: A controlled longitudinal study. Ann Intern Med 123:673-675, 1995
47. Wing RR, Matthews KA, Kuller LH, et al: Weight gain at the time of menopause. Arch Intern Med 151:97-102, 1991
48. Chlebowski RT, Blackburn GI, Buzzard IM, et al: Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. J Clin Oncol 11:2072-2080, 1993
49. Chlebowski RT, Rose D, Buzzard IM, et al: Adjuvant dietary fat intake reduction in postmenopausal breast cancer patient management: The Women's Intervention Nutrition Study (WINS). Breast Cancer Res Treat 20:73-84, 1992
50. de Waard F, Ramlan R, Mulders Y, et al: A feasibility study of weight reduction in obese postmenopausal breast cancer patients. Eur J Cancer Prev 2:233-238, 1993
51. Goodwin PJ, Esplen MJ, Winocur J, et al: Development of a weight management program in women with newly diagnosed breast cancer, in Bitzer J, Stamber M (eds): Psychosomatic Obstetrics and Gynaecology. Bologna, Italy, Monduzzi Editore, International Proceedings Division, 1995, pp 491-496
52. Demark-Wahnefried W, Hars V, Conaway MR, et al: Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy. Am J Clin Nutr 65:1495-1501, 1997
53. Brazel S: Resting Metabolic Rate in Women with Early Stage Breast Cancer. Master of Science Thesis, Department of Nutritional Sciences, University of Toronto, Toronto, Canada, 1997